NuCana Plc - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NuCana Plc - ADR
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
/ 
Frequently asked questions
To buy NuCana Plc - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NuCana Plc - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NuCana Plc - ADR is NCNA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NuCana Plc - ADR has its primary listing on NASDAQ. You can trade NuCana Plc - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NuCana Plc - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NuCana Plc - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NuCana Plc - ADR.